This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Maja Osmak: Innovator in Tumor Treatment
Introduction
Maja Osmak is a notable inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for tumor treatment. Her innovative work has the potential to impact cancer therapy positively.
Latest Patents
Maja Osmak holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which demonstrate cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and exhibit good solubility. These compounds can be utilized in the treatment of tumor patients either as standalone drugs or in combination with other cytostatics.
Career Highlights
Maja Osmak is affiliated with the Ruđer Bošković Institute, where she conducts her research and development work. Her dedication to advancing cancer treatment through innovative compounds showcases her commitment to improving patient outcomes.
Collaborations
Maja has collaborated with esteemed colleagues such as Slovenko Polanc and Tamara Cimbora Zovko, contributing to a dynamic research environment focused on pharmaceutical advancements.
Conclusion
Maja Osmak's contributions to the field of tumor treatment through her innovative patents highlight her role as a significant inventor in the pharmaceutical industry. Her work continues to pave the way for new therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile